Ablative Solutions

About:

Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension.

Website: http://ablativesolutions.com

Twitter/X: ablatvsolutions

Top Investors: Invus Opportunities, Gilde Healthcare, BioStar Capital, CKM Capital Partners, Michigan Accelerator Fund I

Description:

Ablative Solutions is a medical device firm that offers an alternative to surgical renal denervation for treating hypertension. Its technology involves endovascular catheters to provide an efficacious, durable, cost-effective, and safe alternative to surgical renal denervation for the treatment of hypertension and other diseases caused by an overactive sympathetic nervous system.

Total Funding Amount:

$202M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Wakefield, Massachusetts, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)ablativesolutions.com

Founders:

David Fischell, Tim Fischell

Number of Employees:

11-50

Last Funding Date:

2022-06-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai